Vascular Invasion Predicts Recurrence in Stage IA2-IB Lung Adenocarcinoma but not Squamous Cell Carcinoma

被引:3
|
作者
Suaiti, Lubna [1 ]
Sullivan, Travis B. [2 ]
Rieger-Christ, Kimberly M. [2 ]
Servais, Elliot L. [3 ]
Suzuki, Kei [4 ,6 ]
Burks, Eric J. [1 ,2 ,5 ]
机构
[1] Boston Univ, Boston Med Ctr, Dept Pathol & Lab Med, Sch Med, Boston, MA USA
[2] Lahey Hosp & Med Ctr, Dept Translat Res, Ian C Summerhayes Cell & Mol Biol Lab, Burlington, MA USA
[3] Lahey Hosp & Med Ctr, Dept Surg, Burlington, MA USA
[4] Boston Univ, Boston Med Ctr, Dept Surg, Sch Med, Boston, MA USA
[5] Boston Univ Mallory Pathol Associates, Dept Pathol & Labora tory Med, 670 Albany St,Suite 304, Boston, MA 02118 USA
[6] INOVA, Dept Surg, Div Thorac Surg, Falls Church, VA USA
关键词
Lymphovascular; AJCC; NCCN; Pathology; Adjuvant; LYMPHOVASCULAR INVASION; PROGNOSTIC IMPACT; VESSEL INVASION; MICROVASCULAR INVASION; LYMPHATIC INVASION; NUCLEAR-DIAMETER; PRIMARY TUMOR; BLOOD-VESSEL; CANCER; INDICATOR;
D O I
10.1016/j.cllc.2022.12.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
NCCN-guidelines list vascular invasion (VI) as a risk-factor warranting consideration of adjuvant therapy among stage IB NSCLC. Among resected stage IA2-IB LUAD (n =344) and LUSC (n =102), VI predicted worse 5-year RFS for LUAD (64% vs. 90%, P <0.001) but not LUSC (83% vs. 80%, P =0.852). Guidelines should be modified to specify VI as a risk-factor only for stage I adenocarcinoma. Background: Lymphovascular invasion (LVI) is an adverse prognostic feature in resected stage I non-small cell lung cancer (NSCLC); however, it is unclear if the prognostic significance applies to both lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC). Materials and Methods: A retrospective review of H&E-stained slides from surgically resected AJCC 8th ed. stage IA2-IB LUAD (n = 344) and LUSC (n = 102) from two institutions was performed. LVI was defined as either lymphatic (LI) or vascular (VI) invasion. Outcomes were assessed by 5-year recurrence-free survival (RFS) estimates using the Kaplan-Meier method. Results: The cohorts of LUAD and LUSC showed no significant differences in 5-year RFS (81% each), stage, age, race, or surgical procedure. The presence of LVI, VI, and LI was predictive of 5-year RFS for LUAD (LVI + 71% vs. LVI -92%, P < 0.001; VI + 64% vs. VI -90%, P < 0.001; LI + 75% vs. LI -84%, P = 0.030) but not LUSC (LVI + 84% vs. LVI -79%, P = 0.740; VI + 83% vs. VI-80%, P = 0.852; LI + 84% vs. LI -81%, P = 0.757). Among LUAD with LVI, VI was a stronger predictor of 5-year RFS than the remaining subset of VI-LI + tumors (64% vs. 87%, P = 004). Subset analysis of LI among LUAD stratified by VI showed no significant prognostic advantage to adding LI for risk stratification (VI-LI + 87% vs. VI-LI -92%, P = 0.347 & VI + LI + 62% vs. VI + LI-66%, P = 0.422). VI was present in 36% of LUAD. Conclusion: Vascular invasion is a strong predictor of recurrence in stage IA2-IB LUAD but not in LUSC. Adjuvant therapy trials should be directed at this subgroup.
引用
收藏
页码:E126 / E133
页数:8
相关论文
共 50 条
  • [1] Vascular Invasion Predicts Outcome in Early Stage Lung Adenocarcinoma but not Squamous Cell Carcinoma
    Suaiti, Lubna
    Sullivan, Travis
    Suzuki, Kei
    Rieger-Christ, Kimberly
    Burks, Eric
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1345 - 1346
  • [2] Vascular Invasion Predicts Outcome in Early Stage Lung Adenocarcinoma but not Squamous Cell Carcinoma
    Suaiti, Lubna
    Sullivan, Travis
    Suzuki, Kei
    Rieger-Christ, Kimberly
    Burks, Eric
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1345 - 1346
  • [3] Segmentectomy or Wedge Resection in Stage IA Lung Squamous Cell Carcinoma and Adenocarcinoma?
    Li, Guoshu
    Xie, Shuanshuan
    Hu, Feng
    Tan, Min
    Fan, Lihong
    Wang, Changhui
    JOURNAL OF CANCER, 2021, 12 (06): : 1708 - 1714
  • [4] Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma
    Usui, Shingo
    Minami, Yuko
    Shiozawa, Toshihiro
    Iyama, Shinji
    Satomi, Kaishi
    Sakashita, Shingo
    Sato, Yukio
    Noguchi, Masayuki
    LUNG CANCER, 2013, 82 (03) : 407 - 412
  • [5] PROGNOSTIC IMPLICATIONS OF VASCULAR INVASION DIFFER BETWEEN LUNG ADENOCARCINOMA AND SQUAMOUS CELL CARCINOMA
    Usui, Shingo
    Minami, Yuko
    Noguchi, Masayuki
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S450 - S450
  • [6] A comparison of prognoses of FIGO stage IB adenocarcinoma and squamous cell carcinoma
    Ayhan, A
    Al, RA
    Baykal, C
    Demirtas, E
    Yüce, K
    Ayhan, A
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (02) : 279 - 285
  • [7] Increased Risk of Postoperative Recurrence in EGFR-Positive Stage IA to IB Invasive Lung Adenocarcinoma
    Ito, Masaoki
    Miyata, Yoshihiro
    Kushitani, Kei
    Yoshiya, Tomoharu
    Tsutani, Yasuhiro
    Konishi, Kazuo
    Takeshima, Yukio
    Okada, Morihito
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S649 - S649
  • [8] Tumor angiogenesis as a predictor of recurrence in stage Ib squamous cell carcinoma of the cervix
    Dinh, TV
    Hannigan, EV
    Smith, ER
    Hove, MJ
    Chopra, V
    To, T
    OBSTETRICS AND GYNECOLOGY, 1996, 87 (05): : 751 - 754
  • [9] Prognostic significance of thrombomodulin expression and vascular invasion in stage I squamous cell carcinoma of the lung
    Tamura, A
    Hebisawa, A
    Hayashi, K
    Sagara, Y
    Fukushima, K
    Kurashima, A
    Yotsumoto, H
    Mori, M
    Komatsu, H
    LUNG CANCER, 2001, 34 (03) : 375 - 382
  • [10] Lymphovascular invasion predicts recurrence in resected stage I non-small cell lung carcinoma
    Percinel, Sibel
    Saki, Serpil Dizbay
    Savas, Berna
    Enon, Serkan
    Cangir, Ayten Kayi
    VIRCHOWS ARCHIV, 2007, 451 (02) : 532 - 532